Technology is used to grow a patient’s own adult stem cells and will be used by NeoStem in orthopedic conditions. NeoStem obtained an exclusive royalty-bearing license for Asia to use Regenerative ...
MELVILLE, N.Y., Dec. 05, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, ...
A culturing process designed to determine the growth and biological characteristics of the resulting cell population is enough to render stem cells a drug subject to FDA manufacturing and labeling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback